Structural models of the snake venom factor V activators from Daboia russelli and Daboia lebetina

被引:19
作者
Segers, Kenneth [1 ]
Rosing, Jan [1 ]
Nicolaes, Gerry A. F. [1 ]
机构
[1] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands
关键词
RVV-V; LVV-V; serine protease; homology modeling; substrate specificity; exosite; BPTI;
D O I
10.1002/prot.21051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Blood coagulation factor V (FV) is a multifunctional protein that circulates in human plasma as a precursor molecule which can be activated by thrombin or activated factor X (FXa) in order to express its cofactor activity in prothrombin activation. FV activation is achieved by limited proteolysis after Arg709, Arg1018, and Arg1545 in the FV molecule. The venoms of Daboia russelli and Daboia lebetina contain a serine protease that specifically activates FV by a single cleavage at Arg1545. We have predicted the three-dimensional structure of these enzymes using comparative protein modeling techniques. The plasminogen activator from Agkistrodon acutus, which shows a high degree of homology with the venom FV activators and for which a high-quality crystallographic structure is available, was used as the molecular template. The RVV-V and LVV-V models provide for the first time a detailed and accurate structure of a snake venom FV activator and explain the observed sensitivity or resistance toward a number of serine protease inhibitors. Finally, electrostatic potential calculations show that two positively charged surface patches are present on opposite sides of the active site. We propose that both FV activators achieve their exquisite substrate specificity for the Arg1545 site via interactions between these exosites and FV.
引用
收藏
页码:968 / 984
页数:17
相关论文
共 88 条
[1]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[2]   Inhibition of thrombin-catalyzed factor V activation by bothrojaracin [J].
Arocas, V ;
Lemaire, C ;
Bouton, MC ;
Bezeaud, A ;
Bon, C ;
Guillin, MC ;
Jandrot-Perrus, M .
THROMBOSIS AND HAEMOSTASIS, 1998, 79 (06) :1157-1161
[3]   Bothrojaracin: A potent two-site-directed thrombin inhibitor [J].
Arocas, V ;
Zingali, RB ;
Guillin, MC ;
Bon, C ;
JandrotPerrus, M .
BIOCHEMISTRY, 1996, 35 (28) :9083-9089
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   THE REFINED 2.2-A (0.22-NM) X-RAY CRYSTAL-STRUCTURE OF THE TERNARY COMPLEX FORMED BY BOVINE TRYPSINOGEN, VALINE-VALINE AND THE ARG15 ANALOG OF BOVINE PANCREATIC TRYPSIN-INHIBITOR [J].
BODE, W ;
WALTER, J ;
HUBER, R ;
WENZEL, HR ;
TSCHESCHE, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 144 (01) :185-190
[6]  
Bode W, 1997, THROMB HAEMOSTASIS, V78, P501
[7]   THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT [J].
BODE, W ;
MAYR, I ;
BAUMANN, U ;
HUBER, R ;
STONE, SR ;
HOFSTEENGE, J .
EMBO JOURNAL, 1989, 8 (11) :3467-3475
[8]   SINGLE CALCIUM-BINDING SITE OF CRYSTALLINE BOVINE BETA-TRYPSIN [J].
BODE, W ;
SCHWAGER, P .
FEBS LETTERS, 1975, 56 (01) :139-143
[9]  
BODE W, 1992, PROTEIN SCI, V1, P426
[10]   A METHOD TO IDENTIFY PROTEIN SEQUENCES THAT FOLD INTO A KNOWN 3-DIMENSIONAL STRUCTURE [J].
BOWIE, JU ;
LUTHY, R ;
EISENBERG, D .
SCIENCE, 1991, 253 (5016) :164-170